Elevated Mineralocorticoid Receptor Activity in Aged Rat Vascular Smooth Muscle Cells Promotes a Proinflammatory Phenotype via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase and Epidermal Growth Factor Receptor-Dependent Pathways

被引:93
作者
Krug, Alexander W. [1 ]
Allenhoefer, Lena
Monticone, Robert
Spinetti, Gaia
Gekle, Michael [2 ]
Wang, Mingyi
Lakatta, Edward G.
机构
[1] NIA, NIH, Gerontol Res Ctr, Cardiovasc Sci Lab, Baltimore, MD 21224 USA
[2] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Halle, Germany
基金
美国国家卫生研究院;
关键词
aldosterone; arterial aging; vascular smooth muscle cells; mineralocorticoid receptor; inflammation; CARDIOVASCULAR-DISEASE ENTERPRISES; ANGIOTENSIN-II; METABOLIC SYNDROME; MAJOR SHAREHOLDERS; ENDOTHELIAL-CELLS; NADPH OXIDASE; RISK-FACTOR; ALDOSTERONE; ARTERIAL; EXPRESSION;
D O I
10.1161/HYPERTENSIONAHA.109.148783
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Arterial aging is a predominant risk factor for the onset of cardiovascular diseases, such as hypertension, myocardial infarction, or stroke. Aging is associated with intravascular renin-angiotensin system activation, increased vascular stiffness, intima-media thickening, and a proinflammatory phenotype. Little is known about the influence of aldosterone on arterial aging. Hence, we hypothesized that aldosterone and mineralocorticoid receptor (MR) activation might contribute to and possibly accelerate the arterial aging process. We demonstrate increased MR expression in whole aortae and early passage aortic vascular smooth muscle cells from aged (30 months) compared with adult (8 months) F344XBN rats. Sensitivity to aldosterone-induced extracellular signal-regulated kinase 1/ 2 mitogen-activated protein kinase activity is increased in aged cells. MR blockade and extracellular signal-regulated kinase 1/ 2 mitogen-activated protein kinase inhibition prevent age-associated increases of transforming growth factor-beta, intercellular adhesion molecule 1, and procollagen 1. Aldosterone increases expression of proinflammatory marker proteins, shifting the phenotype of adult vascular smooth muscle cells toward the proinflammatory phenotype of aged rats. Epidermal growth factor receptor expression is increased with age and by aldosterone, and inhibition of epidermal growth factor receptor tyrosine kinase decreases age-associated proinflammatory marker expression. Our data support the hypothesis that increased constitutive MR signaling may promote and amplify age-associated inflammation that accompanies arterial aging through increased angiotensin II-stimulated expression of MR and enhanced sensitivity to aldosterone-mediated extracellular signal-regulated kinase 1/2 activation, likely related to increased epidermal growth factor receptor expression. (Hypertension. 2010; 55: 1476-1483.)
引用
收藏
页码:1476 / U349
页数:18
相关论文
共 54 条
[21]   Aldosterone and metabolic syndrome is increased aldosterone in metabolic syndrome patients an additional risk factor? [J].
Krug, Alexander W. ;
Ehrhart-Bornstein, Monika .
HYPERTENSION, 2008, 51 (05) :1252-1258
[22]   Aldosterone stimulates epidermal growth factor receptor expression [J].
Krug, AW ;
Grossmann, C ;
Schuster, C ;
Freudinger, R ;
Mildenberger, S ;
Govindan, MV ;
Gekle, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43060-43066
[23]   Human epidermal growth factor receptor-1 expression renders chinese hamster ovary cells sensitive to alternative aldosterone signaling [J].
Krug, AW ;
Schuster, C ;
Gassner, B ;
Freudinger, R ;
Mildenberger, S ;
Troppmair, J ;
Gekle, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (48) :45892-45897
[24]   Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats [J].
Lacolley, P ;
Labat, C ;
Pujol, A ;
Delcayre, C ;
Benetos, A ;
Safar, M .
CIRCULATION, 2002, 106 (22) :2848-2853
[25]   Arterial aging is risky [J].
Lakatta, Edward G. .
JOURNAL OF APPLIED PHYSIOLOGY, 2008, 105 (04) :1321-1322
[26]   Arterial Aging and Subclinical Arterial Disease are Fundamentally Intertwined at Macroscopic and Molecular Levels [J].
Lakatta, Edward G. ;
Wang, Mingyi ;
Najjar, Samer S. .
MEDICAL CLINICS OF NORTH AMERICA, 2009, 93 (03) :583-+
[27]   Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises Part I: Aging arteries: A "set up" for vascular disease [J].
Lakatta, EG ;
Levy, D .
CIRCULATION, 2003, 107 (01) :139-146
[28]   Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises - Part II: The aging heart in health: Links to heart disease [J].
Lakatta, EG ;
Levy, D .
CIRCULATION, 2003, 107 (02) :346-354
[29]   Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises - Part III: Cellular and molecular clues to heart and arterial aging [J].
Lakatta, EG .
CIRCULATION, 2003, 107 (03) :490-497
[30]   Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach [J].
Lautrette, A ;
Li, SQ ;
Alili, R ;
Sunnarborg, SW ;
Burtin, M ;
Lee, DC ;
Friedlander, G ;
Terzi, F .
NATURE MEDICINE, 2005, 11 (08) :867-874